United Cannabis Corporation v. Pure Hemp Collective Inc. ( 2023 )


Menu:
  • Case: 22-1363   Document: 33     Page: 1   Filed: 05/08/2023
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    UNITED CANNABIS CORPORATION,
    Plaintiff-Appellee
    v.
    PURE HEMP COLLECTIVE INC.,
    Defendant-Appellant
    ______________________
    2022-1363
    ______________________
    Appeal from the United States District Court for the
    District of Colorado in No. 1:18-cv-01922-WJM-NYW,
    Judge William J. Martinez.
    ______________________
    Decided: May 8, 2023
    ______________________
    ORION ARMON, Cooley LLP, Denver, CO, argued for
    plaintiff-appellee.
    JAMES R. GOURLEY, Carstens, Allen, & Gourley, LLP,
    Plano, TX, argued for defendant-appellant.
    ______________________
    Before LOURIE, CUNNINGHAM, and STARK, Circuit Judges.
    Case: 22-1363     Document: 33     Page: 2    Filed: 05/08/2023
    2                           UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    STARK, Circuit Judge.
    United Cannabis Corporation (“UCANN”) sued Pure
    Hemp Collective (“Pure Hemp”) for infringement of 
    U.S. Patent No. 9,730,911
     (the “’911 patent”) in the United
    States District Court for the District of Colorado. After pro-
    longed litigation, UCANN and Pure Hemp stipulated to the
    dismissal of their claims and counterclaims. Pure Hemp
    then moved for attorney fees and sanctions, which the dis-
    trict court denied. Pure Hemp asks us to reverse and de-
    clare this case exceptional. We affirm.
    I
    UCANN filed suit in the District of Colorado in July
    2018, accusing Pure Hemp of infringing the ’911 patent.
    The ’911 patent, entitled “Cannabis Extracts and Methods
    of Preparing and Using the Same,” discloses the “extraction
    of pharmaceutically active components . . . more particu-
    larly . . . botanical drug substance (BDS) comprising can-
    nabinoids obtained by extraction from cannabis.”
    ’911 patent 1:14-17. In April 2020, UCANN filed for bank-
    ruptcy, which automatically stayed this litigation. After
    the bankruptcy petition was dismissed in January 2021,
    the parties stipulated to the dismissal of this patent case.
    UCANN’s infringement claims were dismissed with preju-
    dice while Pure Hemp’s invalidity and inequitable conduct
    counterclaims were dismissed without prejudice. The stip-
    ulation was silent on the issue of attorney fees.
    Subsequently, on April 14, 2021, Pure Hemp moved for
    an award of attorney fees pursuant to 
    35 U.S.C. § 285
    ,
    
    28 U.S.C. § 1927
    , and the district court’s inherent author-
    ity. Pure Hemp asserted two bases for its requested relief:
    (1) UCANN’s prosecution counsel had allegedly committed
    inequitable conduct by copying text from a piece of prior
    art, U.S. Patent Publication No. 2004/0033280 (“Whittle”),
    into the specification of the ’911 patent and then not dis-
    closing Whittle to the Patent and Trademark Office
    (“PTO”) as prior art; and (2) UCANN’s litigation counsel,
    Case: 22-1363     Document: 33        Page: 3   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION     v.                            3
    PURE HEMP COLLECTIVE INC.
    Cooley LLP, purportedly took conflicting positions in its
    representation of UCANN and another client, GW Pharma
    (the owner of Whittle). Pure Hemp expressly notified the
    district court that it did not seek any further proceedings,
    including a trial or evidentiary hearing, in connection with
    its motion. See, e.g., ECF No. 12 at 2 (Pure Hemp reiterat-
    ing to this court it “did not request an evidentiary hearing
    at the district court, and is not requesting one here”). Con-
    sequently, the district court resolved and denied the motion
    for attorney fees based on the existing record. In doing so,
    the district court explained:
    Ultimately, the Court finds that Defendant has
    failed to establish that it is the prevailing party un-
    der section 285, that this is an “exceptional” case
    warranting an attorney’s fee award, or that Plain-
    tiff’s counsel has acted in a vexatious or otherwise
    unreasonable manner. In making this determina-
    tion, the Court notes that the parties stipulated to
    dismissal of this case before many of the factual dis-
    putes Defendant cites were adjudicated on the mer-
    its. (ECF No. 91.) The record on the substantive
    merits and the materiality of Plaintiff’s purport-
    edly inequitable conduct is woefully undeveloped,
    and as such, does not paint a persuasive picture for
    awarding fees.
    J.A. 2-3 (emphasis in original). Pure Hemp timely ap-
    pealed. We have jurisdiction pursuant to 
    28 U.S.C. § 1295
    (a)(1).
    II
    Pure Hemp sought to recover its attorney fees under
    three different legal authorities, so we set out the legal
    standards applicable to our review of each of them.
    First, pursuant to 
    35 U.S.C. § 285
    , “[t]he court in ex-
    ceptional cases may award reasonable attorney fees to the
    prevailing party.” An exceptional case is “simply one that
    Case: 22-1363     Document: 33      Page: 4     Filed: 05/08/2023
    4                            UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    stands out from others with respect to the substantive
    strength of a party’s litigating position (considering both
    the governing law and the facts of the case) or the unrea-
    sonable manner in which the case was litigated.” Octane
    Fitness, LLC v. ICON Health & Fitness, Inc., 
    572 U.S. 545
    ,
    554 (2014). Relevant considerations may include “frivo-
    lousness, motivation, objective unreasonableness (both in
    the factual and legal components of the case) and the need
    in particular circumstances to advance considerations of
    compensation and deterrence.” 
    Id.
     at 554 n.6. In deter-
    mining if a case is exceptional within the meaning of the
    statute, district courts, “in the case-by-case exercise of their
    discretion, consider[] the totality of the circumstances.” 
    Id. at 554
    . The “fee-seeking party must show that it is entitled
    to § 285 fees by a ‘preponderance of evidence.’” Bayer Crop-
    Science AG v. Dow AgroSciences LLC, 
    851 F.3d 1302
    , 1305
    (Fed. Cir. 2017) (quoting Octane Fitness, 
    572 U.S. at
    557-
    58).
    We apply “an abuse-of-discretion standard in review-
    ing all aspects of a district court’s § 285 determination.”
    Highmark Inc. v. Allcare Health Mgmt. Sys., Inc., 
    572 U.S. 559
    , 564 (2014). “To meet the abuse-of-discretion standard,
    the [appellant] must show that the district court made a
    clear error of judgment in weighing relevant factors or in
    basing its decision on an error of law or on clearly errone-
    ous factual findings.” Bayer CropScience, 
    851 F.3d at 1306
    (internal quotation marks omitted).
    Second, 
    28 U.S.C. § 1927
     states:
    Any attorney . . . admitted to conduct cases in any
    court of the United States . . . who so multiplies the
    proceedings in any case unreasonably and vexa-
    tiously may be required by the court to satisfy per-
    sonally the excess costs, expenses, and attorneys’
    fees reasonably incurred because of such conduct.
    We review § 1927 motions under the law of the regional
    circuit. See Gust, Inc. v. Alphacap Ventures, LLC, 905 F.3d
    Case: 22-1363    Document: 33        Page: 5   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                           5
    PURE HEMP COLLECTIVE INC.
    1321, 1327 (Fed. Cir. 2018). The Tenth Circuit has cau-
    tioned that § 1927 is an “extreme standard” and allows for
    relief only when conduct “manifests either intentional or
    reckless disregard of the attorney’s duties to the court.”
    White v. Am. Airlines, Inc., 
    915 F.2d 1414
    , 1427 (10th Cir.
    1990). The Tenth Circuit reviews “an award of sanctions
    under § 1927 only for abuse of discretion,” but where the
    exercise of discretion depends “on the resolution of a purely
    legal issue, . . . we approach such a question de novo.”
    Hamilton v. Boise Cascade Express, 
    519 F.3d 1197
    , 1202
    (10th Cir. 2008). “A district court abuses its discretion
    when it renders an arbitrary, capricious, whimsical, or
    manifestly unreasonable judgment.”           United States
    v. Silva, 
    889 F.3d 704
    , 709 (10th Cir. 2018).
    Third, “in narrowly defined circumstances federal
    courts have inherent power to assess attorney’s fees against
    counsel,” including for acting in “bad faith, vexatiously,
    wantonly, or for oppressive reasons.” Chambers v. NASCO,
    Inc., 
    501 U.S. 32
    , 45-46 (1991) (emphasis added). “When
    reviewing the imposition of sanctions under a district
    court’s inherent powers, we apply the law of the regional
    circuit in which the district court sits.” Monsanto Co.
    v. E.I. Du Pont de Nemours & Co., 
    748 F.3d 1189
    , 1196
    (Fed. Cir. 2014). The Tenth Circuit reviews a district
    court’s sanctions decision made under the court’s inherent
    powers for abuse of discretion. See O’Rourke v. Dominion
    Voting Sys., Inc., 
    2022 WL 17588344
    , at *2 (10th Cir.
    Dec. 13, 2022).
    III
    In asking us to reverse the denial of attorney fees, Pure
    Hemp identifies three supposed errors committed by the
    district court: (1) failing to find Pure Hemp to be the pre-
    vailing party in the litigation; (2) not concluding that the
    undisputed facts establish inequitable conduct; and (3) not
    recognizing that UCANN’s attorneys had a conflict of
    Case: 22-1363     Document: 33      Page: 6    Filed: 05/08/2023
    6                           UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    interest for which they should be sanctioned. 1 We address
    each issue in turn.
    A
    Under § 285, only a prevailing party is eligible to be
    awarded attorney fees. The district court committed error
    in not finding Pure Hemp to be the prevailing party in this
    action. However, this error was harmless.
    “[I]n identifying a prevailing party, we must consider
    whether the district court’s decision effects or rebuffs a
    plaintiff’s attempt to effect a material alteration in the le-
    gal relationship between the parties.” B.E. Tech., L.L.C.
    v. Facebook, Inc., 
    940 F.3d 675
    , 679 (Fed. Cir. 2019) (inter-
    nal quotation marks omitted). Here, UCANN sued Pure
    Hemp for patent infringement and, thereby, attempted to
    effect a material alteration in the parties’ relationship by
    imposing liability on Pure Hemp. This effort failed, as the
    case ended – by agreement – with dismissal of UCANN’s
    patent infringement claims with prejudice. Hence, Pure
    Hemp successfully rebuffed UCANN’s lawsuit and ensured
    that UCANN can never again assert the same patents
    against Pure Hemp’s same accused products; both out-
    comes make Pure Hemp the prevailing party. See Raniere
    v. Microsoft Corp., 
    887 F.3d 1298
    , 1306 (Fed. Cir. 2018)
    (“Appellees ‘won’ through the court’s dismissal of [appel-
    lant’s] case with prejudice – they prevented [appellant]
    1   As UCANN points out, in the district court Pure
    Hemp advocated five grounds for why this case is purport-
    edly exceptional, but it only presses two of these grounds
    on appeal. We agree with UCANN that the other three ba-
    ses are forfeited, see Becton Dickinson & Co. v. C.R. Bard,
    Inc., 
    922 F.2d 792
    , 800 (Fed. Cir. 1990) (“[A]n issue not
    raised by an appellant in its opening brief . . . is waived.”),
    and we need not discuss them.
    Case: 22-1363    Document: 33        Page: 7   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                           7
    PURE HEMP COLLECTIVE INC.
    from achieving a material alteration of the relationship be-
    tween them, based on a decision marked by ‘judicial impri-
    matur.’”); Highway Equip. Co. v. FECO, Ltd., 
    469 F.3d 1027
    , 1035 (Fed. Cir. 2006) (“[W]e conclude that as a mat-
    ter of patent law, the dismissal with prejudice . . . has the
    necessary judicial imprimatur to constitute a judicially
    sanctioned change in the legal relationship of the parties,
    such that the district court properly could entertain [a] fee
    claim under 
    35 U.S.C. § 285
    .”).
    UCANN has never contested, before the district court
    or us, that Pure Hemp is the prevailing party. Instead,
    UCANN argues that the district court’s error on this point
    is harmless because the district court provided additional
    reasons for denying Pure Hemp’s motion. We agree with
    UCANN. After erroneously stating that Pure Hemp had
    not established it was the prevailing party, the district
    court went on to consider the question of whether this case
    is exceptional and concluded that Pure Hemp failed to meet
    its burden on this additional, necessary element of its mo-
    tion. As we explain below, the district court did not abuse
    its discretion in finding this case unexceptional. Therefore,
    the court’s error was harmless. See 
    28 U.S.C. § 2111
     (di-
    recting appellate courts to review cases without regard to
    errors that do not affect parties’ “substantial rights”);
    Bridges v. Wilson, 
    996 F.3d 1094
    , 1099 (10th Cir. 2021)
    (“The appellate court exercises common sense, trying to
    make a realistic assessment of the practical likelihood that
    the result in the district court would have been different
    had the error not occurred.”) (internal quotation marks
    omitted).
    B
    “To prove inequitable conduct, the challenger must
    show by clear and convincing evidence that the patent ap-
    plicant (1) misrepresented or omitted information material
    to patentability, and (2) did so with specific intent to mis-
    lead or deceive the PTO.” In re Rosuvastatin Calcium Pat.
    Case: 22-1363     Document: 33      Page: 8    Filed: 05/08/2023
    8                           UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    Litig., 
    703 F.3d 511
    , 519 (Fed. Cir. 2012). “We review the
    district court’s findings of materiality and intent for clear
    error.” Barry v. Medtronic, Inc., 
    914 F.3d 1310
    , 1333 (Fed.
    Cir. 2019) (alterations in original omitted).
    In this case, we have no findings to review. The district
    court made no findings, and was not required to do so, be-
    cause Pure Hemp voluntarily dismissed its counterclaim
    for inequitable conduct before any such findings had been
    made and, thereafter, in connection with its post-dismissal
    motion for attorney fees, Pure Hemp told the district court
    it did not seek any further evidentiary proceedings. See
    ECF No. 12 at 2 (Pure Hemp acknowledging it “did not re-
    quest an evidentiary hearing at the district court, and is
    not requesting one here”); Oral Arg. at 2:40-45 (Q: “Did you
    request a post-judgment evidentiary hearing?” A: “I did
    not.”). It is self-evident that a district court does not abuse
    its discretion by not conducting a post-dismissal inequita-
    ble conduct proceeding, in aid of resolution of a § 285 mo-
    tion, when the moving party explicitly disclaims any desire
    for such a proceeding. See Thermolife Int’l LLC v. GNC
    Corp., 
    922 F.3d 1347
    , 1357 (Fed. Cir. 2019) (“[W]e have em-
    phasized the wide latitude district courts have to refuse to
    add to the burdens of litigation by opening up issues that
    have not been litigated but are asserted as bases for a fee
    award.”) (emphasis in original).
    Pure Hemp insists that the lack of factual findings on
    either element of an inequitable conduct claim – specific
    intent to deceive the PTO and materiality of the undis-
    closed prior art reference – does not doom its appeal be-
    cause Pure Hemp can satisfy its burden based on the
    undisputed facts in the record. Even assuming this is the-
    oretically possible, Pure Hemp’s contention is unavailing
    here, as the limited record before us reveals genuine dis-
    putes with respect to both elements. The attorney Pure
    Hemp accuses of committing inequitable conduct, Cynthia
    Kozakiewicz, explained why she viewed the Whittle refer-
    ence to be immaterial and why she believed in good faith
    Case: 22-1363    Document: 33        Page: 9   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                           9
    PURE HEMP COLLECTIVE INC.
    she did not have to disclose it to the PTO. See J.A. 282-84.
    That Pure Hemp does not believe this testimony – and that
    Pure Hemp may have been able to prove at a trial, by clear
    and convincing evidence, that Ms. Kozakiewicz acted with
    a specific intent to deceive – is irrelevant. What matters to
    this appeal, and what the district court was free to treat as
    dispositive in denying the motion, is that the record demon-
    strates (at best for Pure Hemp) a genuine dispute as to the
    material fact of intent; meaning Pure Hemp failed to meet
    its burden to prove that this case is exceptional due to in-
    equitable conduct. Pure Hemp did not seek further pro-
    ceedings to try to make the required showing of intent to
    deceive, so it was entirely proper for the district court to
    reject the motion based solely on the limited record before
    it.
    The analysis is much the same on the issue of the ma-
    teriality of the Whittle reference. UCANN made argu-
    ments for non-materiality, and Pure Hemp argued for
    materiality; the procedural posture did not require the dis-
    trict court to resolve this dispute (and it did not), so the
    record continues to contain (at best for Pure Hemp) a gen-
    uine dispute on the material fact of materiality. Thus,
    again, Pure Hemp failed to show that this case is excep-
    tional due to inequitable conduct.
    Pure Hemp places great emphasis on another theory of
    inequitable conduct, which we also conclude lacks merit.
    Pure Hemp points out that UCANN’s prosecution counsel
    copied and pasted portions of Whittle and another prior art
    reference into the ’911 patent application. She did not dis-
    close Whittle to the PTO. In Pure Hemp’s view, this undis-
    closed copying and pasting is inequitable conduct.
    Appellant Br. at 26 (“The lack of disclosure is the problem
    here – not the copying and pasting by itself.”). As support,
    Pure Hemp relies on two district court cases, see CCC
    Group, Inc. v. Martin Engineering Co., 
    683 F. Supp. 2d 1201
     (D. Colo. 2010), and American Calcar, Inc. v. Ameri-
    can Honda Motor Co., 
    2012 WL 1328640
     (S.D. Cal. Apr. 17,
    Case: 22-1363    Document: 33     Page: 10    Filed: 05/08/2023
    10                          UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    2012), aff’d, 
    768 F.3d 1185
     (Fed. Cir. 2014), neither of
    which are binding, and both of which turn on specific facts
    not present here. See CCC Grp., 
    683 F. Supp. 2d at 1209
    (finding inequitable conduct where patent applicant pro-
    vided “a misleading portrayal of prior art” by including fig-
    ure from prior art without identifying source and by
    misstating what figure represented); Am. Calcar, 
    2012 WL 1328640
    , at *5, *8 (finding inequitable conduct where “the
    overwhelming evidence indicate[d] [applicant] used the
    [prior art] while working on the patent application” and
    “the operational details of the [prior art] [were] material”
    to patentability). In both cases, the courts made specific
    findings that the copied prior art was material, while here
    the district court made no such finding. Additionally, Ms.
    Kozakiewicz provided an explanation for her copying and
    pasting – essentially that it was all background infor-
    mation well-known to a person of ordinary skill in the art
    – and the undeveloped record gives us no reason to disbe-
    lieve her testimony. J.A. 282-84, 298.
    Pure Hemp offers another argument for why it can win
    this appeal even if we find, as we have, that the record con-
    tains genuine disputes of material fact: that we can make
    our own findings on intent to deceive and materiality. See,
    e.g., Appellant Br. at 14 (“When this Court considers all of
    the evidence, it can not only reverse the district court’s
    findings, it can also affirmatively hold that this case was
    exceptional . . . .”); 
    id. at 24
     (suggesting this Court could
    find that “[t]he single most reasonable inference based on
    all of the actions during prosecution of the [’]911 Patent is
    that Whittle was withheld from the USPTO with intent to
    deceive”). Pure Hemp fundamentally misunderstands our
    role as a court of appeals. See, e.g., Spineology, Inc. v.
    Wright Med. Tech., Inc., 
    910 F.3d 1227
    , 1230 (Fed. Cir.
    2018) (“We will not force the district court, on a motion for
    attorney fees, to conduct the trial it never had . . . and we
    – an appellate court – will certainly not conduct that trial
    in the first instance.”) (emphasis added); Impax Labs. Inc.
    Case: 22-1363    Document: 33        Page: 11   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                          11
    PURE HEMP COLLECTIVE INC.
    v. Lannett Holdings Inc., 
    893 F.3d 1372
    , 1382 (Fed. Cir.
    2018) (“We do not and should not reweigh evidence or make
    factual findings anew on appeal.”). We reject Pure Hemp’s
    invitation to invade the province of the district court and
    make our own findings of fact.
    Pure Hemp offers one final argument with respect to
    inequitable conduct: that the district court erred in failing
    to provide a more fulsome analysis. This contention, too,
    lacks merit. The district court plainly stated that it consid-
    ered “all of the parties’ arguments,” J.A. 2, and Pure Hemp
    provides no reason for us to question this statement. See
    Novartis AG v. Torrent Pharms. Ltd., 
    853 F.3d 1316
    , 1328
    (Fed. Cir. 2017) (“[T]his court has said on multiple occa-
    sions that failure to explicitly discuss every issue or every
    piece of evidence does not alone establish that the tribunal
    did not consider it.”); Lab. Corp. of Am. Holdings v. Chiron
    Corp., 
    384 F.3d 1326
    , 1332 (Fed. Cir. 2004) (stating that
    district court’s failure to discuss issue did not mean issue
    was not considered). Moreover, “[b]ecause of the high level
    of deference owed to district courts on this issue and the
    limited circumstances that could qualify as exceptional,
    this court has not imposed a blanket requirement that a
    district court provide its reasoning in attorney fee cases.”
    Wedgetail Ltd. v. Huddleston Deluxe, Inc., 
    576 F.3d 1302
    ,
    1305 (Fed. Cir. 2009); see also Serio-US Indus., Inc. v. Plas-
    tic Recovery Techs. Corp., 
    459 F.3d 1311
    , 1322 (Fed. Cir.
    2006) (upholding denial of fees even without any district
    court opinion where “the record as a whole . . . adequately
    supports the denial of attorney fees”). 2 We decline to im-
    pose such a requirement now.
    2    “Instead, we have held only that a statement of the
    district court’s reasoning is generally necessary to enable
    review when an attorney fees motion is granted or when
    attorney fees are denied despite the presence of one or more
    of the [following] circumstances”: “inequitable conduct
    Case: 22-1363    Document: 33      Page: 12     Filed: 05/08/2023
    12                          UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    C
    Pure Hemp additionally argues that this case is excep-
    tional because UCANN’s attorneys suffered from a conflict
    of interest for which they should be sanctioned. We reject
    this argument because it is waived. Pure Hemp did not cite
    Rule 1.7 of the Model Rules of Professional Conduct, which
    is the basis for its conflict contention before us, to the dis-
    trict court. See In re Google Tech. Holdings LLC, 
    980 F.3d 858
    , 863 (Fed. Cir. 2020) (“We have regularly stated and
    applied the important principle that a position not pre-
    sented in the tribunal under review will not be considered
    on appeal in the absence of exceptional circumstances.”).
    Pure Hemp’s allegations also lack merit. 3 Rule 1.7 di-
    rects that “a lawyer shall not represent a client if the rep-
    resentation involves a concurrent conflict of interest,” and
    goes on to define a concurrent conflict of interest as includ-
    ing where (as arguably relevant here) “the representation
    of one client will be directly adverse to another client.” To
    evaluate whether UCANN suffers from such a conflict, we
    must look to “the total context.” Dr. Falk Pharma GmbH
    v. GeneriCo, LLC, 
    916 F.3d 975
    , 982 (Fed. Cir. 2019). Here,
    the predominant feature of the context is the lack of evi-
    dence. While Pure Hemp alleges that Cooley simultane-
    ously took conflicting positions for two of its clients, by
    prosecuting identical patents for both UCANN and GW
    Pharma, see Appellant Br. at 28 (“Cooley attorneys were
    before the PTO; litigation misconduct; vexatious, unjusti-
    fied, and otherwise bad faith litigation; a frivolous suit or
    willful infringement.” Wedgetail, 
    576 F.3d at 1304-05
     (in-
    ternal citations omitted). None of these circumstances is
    present here.
    3  We apply regional circuit law to the issue of conflict
    of interest. See Monsanto, 
    748 F.3d at 1196
    .
    Case: 22-1363    Document: 33        Page: 13   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                          13
    PURE HEMP COLLECTIVE INC.
    taking different positions in different forums on a critical
    issue: who invented a liquid cannabinoid formulation
    wherein at least 95% of the total cannabinoids is CBD.”), it
    has presented no evidence that the patents Cooley prose-
    cuted and obtained are identical. See J.A. 205-06 (Pure
    Hemp’s district court argument, which is devoid of evi-
    dence). Pure Hemp also failed to show that anything Coo-
    ley did in its representation of UCANN was directly
    adverse to the interests of GW Pharma, or vice versa.
    Therefore, even if we were to reach the merits, we would
    reject Pure Hemp’s argument that this case is exceptional
    due to an unproven conflict of interest suffered by
    UCANN’s attorneys at Cooley. 4
    IV
    Finally, we address whether Pure Hemp’s appeal is
    frivolous. We do so because UCANN previously moved to
    sanction Pure Hemp for a frivolous appeal and it is our un-
    derstanding, based on the briefing and oral argument, that
    UCANN continues to view this appeal as frivolous. See
    Oral Arg. at 18:01-27. We denied the prior motion without
    prejudice, to allow UCANN to potentially renew its motion
    after disposition of the merits of the appeal. ECF No. 15.
    Rather than requiring the parties to brief a motion we
    know we would deny, we take this opportunity to explain
    why, although a close call, we deem this appeal not frivo-
    lous.
    As we have explained:
    4   Particularly given the lack of evidence, Pure Hemp
    is not helped by its citation to two non-binding district
    court cases. See Straight Path IP Grp., Inc. v. Cisco Sys.,
    Inc., 
    2020 WL 2539002
     (N.D. Cal. May 19, 2020); Andersen
    Mfg. v. Wyers Prods. Grp., 
    2019 WL 4007772
     (D. Colo. Aug.
    23, 2019).
    Case: 22-1363     Document: 33      Page: 14    Filed: 05/08/2023
    14                           UNITED CANNABIS CORPORATION v.
    PURE HEMP COLLECTIVE INC.
    [T]here are two senses in which an appeal can be
    held frivolous: First where an appeal is taken in a
    case in which “the judgment by the tribunal below
    was so plainly correct and the legal authority con-
    trary to appellant’s position so clear that there re-
    ally is no appealable issue,” the appeal is held to be
    “frivolous as filed.” Second, even in cases in which
    genuinely appealable issues may exist, so that the
    taking of an appeal is not frivolous, the appellant’s
    misconduct in arguing the appeal may be such as
    to justify holding the appeal to be “frivolous as ar-
    gued.”
    Romala Corp. v. United States, 
    927 F.2d 1219
    , 1222 (Fed.
    Cir. 1991) (internal citations omitted); see also Fed. R. App.
    P. 38.
    While Pure Hemp’s position is extremely weak, it is
    neither “frivolous as filed” nor “frivolous as argued.” Pure
    Hemp has prevailed on its appeal from the district court’s
    erroneous conclusion that Pure Hemp was not the prevail-
    ing party. While UCANN never contested this point, Pure
    Hemp’s victory on it persuades us that its appeal was not
    entirely frivolous when filed. As for how it has argued its
    appeal, there is much on which to fault Pure Hemp, includ-
    ing its contentions that the fact-laden issue of an attorney’s
    specific intent can be resolved on our record as undisputed
    and that, alternatively, we should sit as factfinders. Then
    there are Pure Hemp’s unsupported attacks on the integ-
    rity of UCANN’s prosecution counsel (as discussed above in
    connection with inequitable conduct) and on UCANN’s lit-
    igating counsel (whom Pure Hemp, unconvincingly, ac-
    cuses of misconduct on appeal). See, e.g., Appellant Reply
    Br. at 8 (“United Cannabis has misrepresented the con-
    tents of Whittle in its response brief.”), id. at 20 (“It ap-
    pears that United Cannabis has presented false testimony
    to this Court in support of its position.”), id. at 21 (“And
    now, this tribunal has been presented with additional evi-
    dence of litigation misconduct on the part of Cooley in its
    Case: 22-1363    Document: 33        Page: 15   Filed: 05/08/2023
    UNITED CANNABIS CORPORATION    v.                          15
    PURE HEMP COLLECTIVE INC.
    representation of United Cannabis.”). We take this oppor-
    tunity to remind counsel of their obligation not to lightly
    launch attacks on one another’s integrity and most cer-
    tainly not to do so without a sound basis and solid evidence.
    Although we are not pleased with how Pure Hemp has ar-
    gued this appeal, we cannot say this appeal, as a whole,
    was “frivolous as argued.”
    Accordingly, having sua sponte raised the issue of
    whether this appeal was frivolous, we conclude it was not.
    V
    While we have expressly discussed only the § 285 basis
    for Pure Hemp’s fee motion, our analysis applies equally to
    the other grounds on which Pure Hemp relied: § 1927 and
    the court’s inherent authority. Pure Hemp’s motion fails
    on those grounds as well. We have considered Pure Hemp’s
    remaining arguments and find them unpersuasive. For the
    foregoing reasons, we affirm.
    AFFIRMED
    COSTS
    Costs to Appellee.
    

Document Info

Docket Number: 22-1363

Filed Date: 5/8/2023

Precedential Status: Precedential

Modified Date: 5/8/2023

Authorities (23)

Becton Dickinson and Company v. C.R. Bard, Inc. , 922 F.2d 792 ( 1990 )

Bayer Cropscience Ag v. Dow Agrosciences LLC , 851 F.3d 1302 ( 2017 )

Romala Corporation, a Delaware Corporation v. The United ... , 927 F.2d 1219 ( 1991 )

Highmark Inc. v. Allcare Health Management System, Inc. , 134 S. Ct. 1744 ( 2014 )

Spineology, Inc. v. Wright Medical Technology Inc. , 910 F.3d 1227 ( 2018 )

Ccc Group, Inc. v. Martin Engineering Co. , 683 F. Supp. 2d 1201 ( 2010 )

Raniere v. Microsoft Corporation , 887 F.3d 1298 ( 2018 )

Joe L. White, Plaintiff-Appellee/cross-Appellant v. ... , 915 F.2d 1414 ( 1990 )

Laboratory Corporation of America Holdings, Laboratory ... , 384 F.3d 1326 ( 2004 )

Novartis AG v. Torrent Pharmaceuticals Ltd. , 853 F.3d 1316 ( 2017 )

United States v. Silva , 889 F.3d 704 ( 2018 )

Barry v. Medtronic, Inc. , 914 F.3d 1310 ( 2019 )

Dr. Falk Pharma Gmbh v. Generico, LLC , 916 F.3d 975 ( 2019 )

Thermolife International LLC v. Gnc Corporation , 922 F.3d 1347 ( 2019 )

Octane Fitness, LLC v. Icon Health , 188 L. Ed. 2d 816 ( 2014 )

Monsanto Co. v. E.I Du Pont De Nemours & Co. , 748 F.3d 1189 ( 2014 )

Serio-US Industries, Inc. v. Plastic Recovery Technologies ... , 459 F.3d 1311 ( 2006 )

Highway Equipment Company, Inc., Plaintiff-Cross v. Feco, ... , 469 F.3d 1027 ( 2006 )

American Calcar, Inc. v. American Honda Motor Co. , 768 F.3d 1185 ( 2014 )

Wedgetail, Ltd. v. Huddleston Deluxe, Inc. , 576 F.3d 1302 ( 2009 )

View All Authorities »